Can Xu

机构：University of Electronic Science and Technology of China, Sichuan University, West China Hospital of Sichuan University, Ministry of Agriculture and Rural Affairs, Shanghai Ocean University · ORCID：0009-0006-8604-3790

发表论文 48 篇 · 总被引 1186 次 · h-index 16

代表论文

• Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy (2022 · Neuro-Oncology · 被引 121)
• PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma (2022 · Frontiers in Immunology · 被引 69)
• A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma (2022 · Neuro-Oncology · 被引 64)
• Origin, activation, and targeted therapy of glioma-associated macrophages (2022 · Frontiers in Immunology · 被引 56)
• Single-Cell Transcriptomics of Glioblastoma Reveals a Unique Tumor Microenvironment and Potential Immunotherapeutic Target Against Tumor-Associated Macrophage (2021 · Frontiers in Oncology · 被引 38)
• lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy (2022 · Frontiers in Oncology · 被引 33)